Trial Number

528-24

Condition

Stroke

Participant Age Range

18 years to 90 years

Participant Gender

Any

Enrolling Participants

Yes

Overview

Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Phase 2/3 Study to Evaluate the Efficacy and Safety of JX10 in Acute Ischemic Stroke with Late Presentations

This study is designed to evaluate the Efficacy and safety of JX10 in Acute Ischemic Stroke with Late Presentations

Provider

Related Clinical Trials

Click on the category you are interested in.

Name
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.